Tempus Labs a technology company involved in cancer research and helping patients with treatment located in Chicago has recently raised 80 million dollars in recent unicorn funding. This new funding raise has brought Tempus Labs to a total of 210 million dollars raised. Tempus is a fast-growing new company that was launched only 2 years ago. They are making lots of progress and very quickly to be able to help make a difference in the world of cancer treatments.
Unlike many other cancer treatment research companies Tempus tends to focus much more on their patient’s needs and supporting them instead of focusing solely on the money aspect that is brought about by cancer treatment research. This strategy allows them to build very tight bonds with their patients as well as the loved ones of their patients so that they can continue to help not only their patients but help anyone in the future who may have to go through cancer treatments. They also make it their mission to find ways to make treatments easier and more effective for cancer patients.
Tempus Labs would not be where it is today without the help of their co-founder Eric Lefkofsky. Lefkofsky is all for enhancing the quality of human life as that is his main goal in doing what he has done and what he mainly brings to Tempus labs. Along with bringing his goals for enhancing the quality of human life he also brings to the table first-hand experience of a loved one going through cancer treatment. He knows what his patients are not only going through but mainly what their loved ones are going through and knows better than most how to accommodate his patients as well as their families through this rough process of cancer patients receiving treatment.
Now that Tempus has received this unicorn funding they will not only be able to continue to enhance their research into making cancer treatments more effective and less strenuous on patients but they will also be able to reach any future goals they have when it comes to funding and their needs as a whole.
To Know More Click Here